LM Funding America, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

Stockholders' Equity

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Stockholders' Equity

Note 8. Stockholders’ Equity

Stock Options

The 2015 Omnibus Incentive Plan provides for the issuance of stock options, stock appreciation rights, performance shares,

performance units, restricted stock, restricted stock units, shares of our common stock, dividend equivalent units, incentive cash

awards or other awards based on our common stock. Awards may be granted alone or in addition to, in tandem with, or (subject to the

2015 Omnibus Incentive Plan’s prohibitions on repricing) in substitution for any other award (or any other award granted under

another plan of ours or of any of our affiliates).

The following is a summary of the stock option plan activity during the Three Months ended March 31, 2021 and 2020:

	2021				2020
	Number of		Weighted Average		Number of		Weighted Average
	Options		Exercise Price		Options		Exercise Price
Options Outstanding at Beginning of the year		3,860	$	302.55		3,860	$	302.55
Granted		-		-		-		-
Exercised		-		-		-		-
Adjustment		-		-		-		-
Forfeited		-		-		-		-

Options Outstanding at March 31,		3,860	$	302.55		3,860	$	302.55

Options Exercisable at March 31,		3,193	$	320.00		2,360	$	422.45

Compensation expense recognized from the vesting of stock options was approximately $nil and $3,400 for the Three Months ended March 31, 2021 and 2020. There was no unrecognized compensation cost associated with unvested stock options as of March 31, 2021.

The aggregate intrinsic value of the outstanding common stock options as of March 31, 2021 and December 31, 2020 was approximately $0 and $0 respectively.

Warrants

The following is a summary of the warrant activity during the Three Months ended March 31, 2021 and 2020:

	2021				2020
	Number of		Weighted Average		Number of		Weighted Average
	Warrants		Exercise Price		Warrants		Exercise Price
Warrants Outstanding at Beginning of the year		2,718,012	$	4.20		771,857	$	27.25

Granted		-		-		-		-
Exercised		2,326,112		4.08		-		-
Forfeited		-		-		-		-

Warrants Outstanding at March 31,		391,900	$	4.35		771,857	$	27.25

During the three months ended March 31, 2021, the Company received approximately $9.5 million upon the exercise by warrant holders of warrants for approximately 2.3 million shares. The aggregate intrinsic value of the outstanding common stock warrants as of March 31, 2021 and December 31, 2020 was approximately $797,000 and $256,400 respectively.